http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 06 Mar 2026 08:01:03 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Canaccord analyst Luke Hannan lowered the price target on Cresco Labs Inc. (CL:CN) (OTC: CRLBF) to Cdn$2.25 (from Cdn$2.50) while maintaining a Spec. Buy rating. http://www.streetinsider.com/Intl+Ratings/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Fri, 06 Mar 2026 08:01:03 -0500 CRLBF http://www.streetinsider.com/Intl+Ratings/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Canaccord analyst Luke Hannan lowered the price target on Cresco Labs Inc. (CL:CN) (OTC: CRLBF) to Cdn$2.25 (from Cdn$2.50) while maintaining a Spec. Buy rating. http://www.streetinsider.com/Intl+Ratings/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Fri, 06 Mar 2026 08:01:03 -0500 CRLBF http://www.streetinsider.com/Analyst+PT+Change/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Canaccord analyst Luke Hannan lowered the price target on Cresco Labs Inc. (CL:CN) (OTC: CRLBF) to Cdn$2.25 (from Cdn$2.50) while maintaining a Spec. Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Fri, 06 Mar 2026 08:01:03 -0500 CRLBF http://www.streetinsider.com/Analyst+PT+Change/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Canaccord analyst Luke Hannan lowered the price target on Cresco Labs Inc. (CL:CN) (OTC: CRLBF) to Cdn$2.25 (from Cdn$2.50) while maintaining a Spec. Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+PT+Lowered+to+Cdn%242.25+at+Canaccord/26122356.html Fri, 06 Mar 2026 08:01:03 -0500 CRLBF http://www.streetinsider.com/SEC+Filings/Form++40-F+++++++Cresco+Labs+Inc.++++++++++For%3A+Dec+31/26121583.html si-local-file:///var/storage/secattach/20260306/26121583.html http://www.streetinsider.com/SEC+Filings/Form++40-F+++++++Cresco+Labs+Inc.++++++++++For%3A+Dec+31/26121583.html Fri, 06 Mar 2026 06:00:00 -0500 CL CRLBF O.02619105 http://www.streetinsider.com/SEC+Filings/Form++40-F+++++++Cresco+Labs+Inc.++++++++++For%3A+Dec+31/26121583.html si-local-file:///var/storage/secattach/20260306/26121583.html http://www.streetinsider.com/SEC+Filings/Form++40-F+++++++Cresco+Labs+Inc.++++++++++For%3A+Dec+31/26121583.html Fri, 06 Mar 2026 06:00:00 -0500 CL CRLBF O.02619105 http://www.streetinsider.com/SEC+Filings/Form++40-F+++++++Cresco+Labs+Inc.++++++++++For%3A+Dec+31/26121583.html si-local-file:///var/storage/secattach/20260306/26121583.html http://www.streetinsider.com/SEC+Filings/Form++40-F+++++++Cresco+Labs+Inc.++++++++++For%3A+Dec+31/26121583.html Fri, 06 Mar 2026 06:00:00 -0500 CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Press+Releases/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54438956&amp;newsitemid=20260305447476&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=3f8059099c2a90e0dc8b2b46436ab7e5" shape="rect">here</a>. </p><p> <b>Fiscal Year 2025 Highlights</b> </p><ul class="bwlistdisc"> <li> Revenue of $656 million. Operating http://www.streetinsider.com/Business+Wire/Cresco+Labs+Delivers+Q4+2025+Revenue+of+%24162+Million+and+Sequential+Margin+Improvement/26114679.html Thu, 05 Mar 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Press+Releases/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Business+Wire/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Business+Wire/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=54429907&amp;newsitemid=20260220312820&amp;lan=en-US&amp;anchor=Cresco+Labs+Inc.&amp;index=1&amp;md5=b6a8135d9d370b5167a778da6ad94887" shape="rect">Cresco Labs Inc.</a> (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. </p><p> The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. </p><p class="bwmarginl1"> <b>Event</b>: Cresco Labs Fourth Quarter 2025 Earnings Conference Call <br /><b>Date</b>: Thursday, March 5, 2026 <br http://www.streetinsider.com/Business+Wire/Cresco+Labs+to+Report+Fourth+Quarter+2025+Financial+Results+on+March+5%2C+2026/26038847.html Mon, 23 Feb 2026 06:30:00 -0500 6CQ 6CQ CL CRLBF O.02619105